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Summary 
Acute mountain sickness is common amongst not acclimatized persons ascending to high-
altitude; the underlying mechanism is unknown, but may be related to cerebral edema. Nine 
healthy male students were studied before and after 6-hours exposure to isobaric hypoxia. 
Subjects inhaled room air enriched with N2 to obtain SaO2 values of 75-80%. Acute mountain 
sickness was assessed with the environmental symptom questionnaire, and cerebral edema 
with 3 Tesla magnetic resonance imaging in 18 regions of interest in the cerebral white 
matter. The main outcome measures were development of intra- and extracellular cerebral 
white matter edema assessed by visual inspection and quantitative analysis of apparent 
diffusion coefficients, derived from diffusion-weighted imaging, and B0 signal intensities, 
derived from T2-weighted imaging. Seven of nine subjects developed acute mountain 
sickness. Mean apparent diffusion coefficient increased 2.12% (baseline, 0.80 ± 0.09; 6-hours 
hypoxia, 0.81 ± 0.09; p=0.034), and mean B0 signal intensity increased 4.56% (baseline, 
432.1 ± 98.2; 6-hours hypoxia, 450.7 ± 102.5; p<0.001). Visual inspection of magnetic 
resonance images failed to reveal cerebral edema. Cerebral acute mountain sickness scores 
showed a negative correlation with relative changes of apparent diffusion coefficients (r=-
0.83, p=0.006); there was no correlation with relative changes of B0 signal intensities. In 
conclusion, isobaric hypoxia is associated with mild extracellular (vasogenic) cerebral edema 
irrespective of the presence of acute mountain sickness in most subjects, and severe acute 
mountain sickness with additional mild intracellular (cytotoxic) cerebral edema. 
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Introduction 
Unacclimatized subjects, who rapidly ascent to high-altitude, may develop acute mountain 
sickness (AMS) that is characterized by headache, anorexia, nausea, vomiting, insomnia and 
dizziness (Basnyat and Murdoch, 2003;Hackett and Roach, 2001;Levine et al., 1989;Roach et 
al., 1993). The underlying mechanism for AMS is unclear. Intracellular (cytotoxic) cerebral 
edema, extracellular (vasogenic) cerebral edema, and increased cerebral blood volume have 
all been implicated, but without convincing scientific evidence (Basnyat and Murdoch, 
2003;Hackett and Roach, 2001;Sutton and Lassen, 1979). Some magnetic resonance imaging 
(MRI) studies, using 1.5 Tesla machines, found that exposure to moderate hypo- or isobaric 
hypoxia, corresponding to altitudes of 4500 m, increased brain volume by 0.5-2.8% 
(Kallenberg et al., 2006;Morocz et al., 2001) and decreased cerebrospinal fluid volume in the 
lateral and third ventricles by 10.3% (Fischer et al., 2004). Results with respect to the 
presence and type of cerebral edema were, however, conflicting (Fischer et al., 
2004;Kallenberg et al., 2006;Matsuzawa et al., 1992;Morocz et al., 2001). This could have 
been related to the relatively low resolution of 1.5 Tesla MRI and because the MR images 
were only visually evaluated and not analyzed with more sensitive quantitative methods.  
In the present study, we used 3 Tesla MRI to investigate whether experimental hypoxia-
induced AMS is associated with intra- and/or extracellular cerebral edema. We compared 
diffusion-weighted (DWI) and T2-weighted (T2WI) MR images obtained before and after 6-
hours exposure to isobaric hypoxia by visual inspection and quantitative analysis of apparent 
diffusion coefficients (ADCs) derived from DWI, and B0 signal intensities derived from 
T2WI.  
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Materials and methods 
Subjects 
Nine healthy male volunteers (mean age 26.4 ± 3.5 years) were recruited from students of the 
University of Zurich, Switzerland. Exclusion criteria were: altitude exposure (>1500 m) in the 
previous 3 months, a history of smoking, substance and drug abuse, or of lung, cardiac, 
neurological or psychiatric disease, and contraindication to undergo MRI (e.g., pacemaker). 
The local medical ethical committee approved the study protocol, and written informed 
consent was obtained from all subjects. 
 
Study design 
The study subjects were in supine position and were fitted a facial mask which was connected 
with a tube of 3 m length. The total flow of fresh gas varied between 9 to 12 liters per minute, 
because 6 liters of compressed air per minute were mixed with 3 to 6 liters of N2 per minute. 
Thus, the stimulus was assumed to cause poikilocapnic hypoxia. Baseline examinations were 
done when the subjects were familiarized with the facial mask and the attached tube, and 
included assessment of the cerebral symptoms of AMS (AMS-C) by completion of the 
environmental symptom questionnaire (ESQ)(Sampson et al., 1983), monitoring of arterial 
O2 saturation (SaO2), the measurement of the blood pressure, and baseline MRI. The supine 
subjects were then transported to a room adjacent to the MR suite, and the tube was connected 
with a gas container. Here, one investigator gradually increased the concentration of N2 in the 
inspired air, over a period of 20 minutes, to obtain SaO2 values of 75 to 80%. This 
corresponds to an altitude of about 4500 m. The SaO2 values were measured using a fingertip 
pulse oximeter (Datex-Ohmeda, Helsinki, Finland). End-tidal pCO2 was not determined for 
technical reasons. The SaO2 was kept stable during the following 6 hours and the second 
MRI study by adjusting the mixture of inspired gas. After 6 hours of hypoxia, the subjects 
were transported in the supine position to the MR suite for the second MRI study. Symptoms 
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of AMS and blood pressure were re-assessed every hour, and finally during the second MRI 
study. 
 
MRI studies 
MRI studies were performed using a 3 T Philips Intera whole body system (Philips Medical 
Systems, Best, The Netherlands). Identical protocols and volume positioning were used at 
baseline and during hypoxia. The DWI data were based on a spin-echo single excitation echo-
planar imaging protocol. Whole brain scans with an in-plane resolution of 1.6 x 1.6 mm2 (14 
contiguous slices, slice thickness = 4 mm, matrix = 1282, echo time = 79 ms, relaxation time 
= 3987 ms) were carried out along three orthogonal diffusion directions with a diffusion 
weighting of b = 1000 s/mm2, of b=0(Patel et al., 1995) and of B0 images (T2* weighted 
images from the same sequence, with no applied diffusion gradient). An isotropic diffusion-
weighted image (Figure 3A) was calculated as the geometric mean of three orthogonal 
diffusion-weighted images. Additionally, for each slice a T2WI with minimal diffusion 
weighting (b < 20 s/mm2) was acquired. The duration for the imaging procedure including the 
diffusion and the T2 protocol was 4 min and 6 s. 
The MRI data were stored and independently analyzed after completion of the study by 
investigators who were not aware of the cerebral AMS (AMS-C) scores. Two physicists (TJ 
and UD) and neurologists (PSS and RWB), blinded to the AMS scores, looked for the 
presence of cerebral edema by comparing the second DWI and T2WI scans of each subject 
with the corresponding baseline scans (Figure 3). Another neurologist (ACN), also blinded to 
the AMS scores, measured the ADC values and B0 signal intensities in 22 regions of interest 
(ROI) as the average value of all pixels in the respective ROI.  
The ROIs were circular and located on four consecutive slices (Figure 1). Slice A and B were 
placed above, and the next two slices at the level of the cella media of the lateral ventricles. 
Eighteen of 22 ROIs were located in the cerebral white matter (nine in each hemisphere), and 
the other four in the cerebrospinal fluid (CSF) of both lateral ventricles. Cerebral white matter 
ROI were located in the anterior part in eight cases (beside the forceps minor; two 
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measurements per slice), the middle part for two ROIs (beside the lateral ventricles; two 
measurements on the lowest slice), and the posterior part for eight ROIs (next to the forceps 
major, which corresponds to the lateral part of the corpus callosum fibers; two measurements 
per slice). Each white matter ROI consisted of 88 pixels, and each CSF ROI of 16 pixels. CSF 
ROIs contained fewer pixels than ROIs in the white matter, because not all ventricles were 
wide enough to accommodate larger circles. The use of smaller reference ROI in the CSF is 
appropriate, since the MRI signal is higher in the CSF than the white matter and thus provides 
a better signal-to-noise ratio. MRI signal intensities are arbitrary units with different absolute 
values at baseline and 6-hours sessions. Therefore, ROIs placed in the CSF were used to 
correct for intersession differences, because the CSF signal levels are assumed to remain 
unchanged during hypoxia. All ADC values and B0 signal intensities measured after 6-hours 
were thus corrected to achieve the same values in CSF as at baseline according to the 
proportion: ROI6-hours corrected = ROI6-hours x CSFbaseline / CSF6-hours, where CSF is the mean value 
of all CSF ROIs. 
 
Interpretation of ADC and B0 changes on MRI 
Increase of both ADC and B0 values are indicative of extracellular (vasogenic) edema, whilst 
an increase of B0 values in combination with a decrease of ADC values is indicative for the 
development of intracellular (cytotoxic) edema (Brunberg et al., 1995;Kucharczyk et al., 
1993;Mintorovitch et al., 1991;Mintorovitch et al., 1994;Tien et al., 1994).  
 
Assessment of AMS 
The ESQ was translated to German and used as described previously (Bartsch et al., 1990). 
Subjects were considered to suffer from AMS when the AMS-C score was 0.70(Sampson et 
al., 1983). The AMS-C score ranges from 0-5 and is based on eleven neurological symptoms. 
 
Statistical analysis 
Statistical analysis was performed using SPSS 12.0 (SPSS, Chicago, Illinois).  
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Mean ADC (primary outcome of the study) and B0 values obtained at baseline and after 6 
hours were compared using a general linear model for repeated measurements including ROI 
location as covariate (total white matter ROI, n=162; anterior white matter ROI, n=72; middle 
white matter ROI, n=18; posterior white matter ROI, n=72). Associations between AMS-C 
scores and relative changes of ADCs and B0 signal intensities were assessed using the non-
parametric Spearman correlation coefficients. P <0.05 was considered significant. 
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Results 
All nine subjects completed the study. The data set was complete and was evaluated for all 9 
subjects. Seven out of nine subjects (subjects 2-6, 8, 9) developed AMS during hypoxia. Six 
of the nine subjects had AMS during the second MRI scan (Figure 2). Baseline blood pressure 
did not differ between subjects with and without AMS. The mean AMS score of all subjects 
was higher at the time of MRI scanning than at baseline (Table 1). 
Systolic (baseline, 113  9 mm Hg; during second MRI study, 115  11 mm Hg; p=0.49) and 
diastolic (baseline, 72  6 mm Hg; during second MRI study, 74  4 mm Hg; p=0.71) blood 
pressure did not change during the study (values are means ± standard deviation).  
 
MRI study 
Visual inspection showed no evidence for cerebral edema (Figure 3). 
Mean ADCs were increased by 2.12% (p=0.034, Table 1), and mean B0 values were 
increased by 4.56% (p<0.01, Table 2) after 6-hours exposure to hypoxia. The ADCs increased 
in 6 subjects (Figure 4), and B0 values in 8 subjects (Figure 5). ADCs (p=0.32) and B0 values 
(p=0.06) did not differ between the 3 white matter ROIs.  
As shown in Figure 6, the AMS-C scores measured after 6-hours exposure to hypoxia showed 
a negative correlation with the relative change of ADC values (Spearman correlation 
coefficient -0.83, p = 0.006). There was no association between the AMS-C scores measured 
after 6-hours exposure to hypoxia and the relative change of B0 values (Spearman correlation 
coefficient -0.22, p = 0.576; Figure 7). 
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Discussion 
In the present 3 Tesla MRI study, we found that experimental isobaric hypoxia for six hours: 
1) caused AMS in seven (77%) of nine healthy volunteers; 2) produced a mild extracellular 
(vasogenic) cerebral edema, irrespective of the presence of AMS, which was identified by a 
small increase of both ADCs and B0 values, whereas visual inspection of the MRI data failed 
to detect any differences; and 3) that the AMS-C scores were negatively correlated with the 
ADC values. The prevalence of AMS in this series is in accordance with the results of two 
previous studies exposing 31 subjects to isobaric hypoxia corresponding to altitudes of 4500-
4564 m during 9-16 hours (Kallenberg et al., 2006;Roach et al., 1996). In the study of Roach 
et al. (1996), 6 (67%) of 9 subjects developed AMS, and in the study of Kallenberg et al. 
(2006) 11 (50%) of 22 subjects were affected by this altitude illness.  
The fact that the mild extracellular (vasogenic) cerebral edema was just detected by 
quantitative but not visual analysis of the MRI data is in accordance with the results obtained 
in three 1.5 T MRI investigations (Fischer et al., 2004;Kallenberg et al., 2006;Morocz et al., 
2001). These studies found no cerebral edema at visual inspection of T2WI and DWI in 41 
subjects with mild to moderate AMS who were exposed to hypobaric or isobaric hypoxia 
corresponding to altitudes of 4500-4572 m for 10 to 32 hours (Fischer et al., 2004;Kallenberg 
et al., 2006;Morocz et al., 2001). Furthermore, one of these 3 studies found a mild 
extracellular cerebral edema with increased B0 values and a trend for decreased ADCs 
(Kallenberg et al., 2006). The higher resolution and signal-to-noise ratio of 3 Tesla MRI used 
in the present study makes it more sensitive for detecting cerebral abnormalities (Scarabino et 
al., 2003) than 1.5 Tesla MRI employed in previous AMS investigations (Fischer et al., 
2004;Kallenberg et al., 2006;Morocz et al., 2001). Despite this, visual inspection even of 3 
Tesla MRI brain images was still not sensitive enough to detect the cerebral edema associated 
with AMS. This is in sharp contrast to high altitude cerebral edema (HACE). Here visual 
inspection of  proton density- and T2-weighted MRI brain images revealed extracellular 
edema of the white cerebral matter at a mean of 58 hours (range, 16 to 132 hours) after the 
onset of HACE symptoms (Hackett et al., 1998). 
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There was no association between AMS-C scores and BO signal intensities in this series, 
which confirms the results of a previous study (Kallenberg et al., 2006). In this respect it is 
important to note that, in reality, the degree of extracellular brain edema might have been 
higher. The B0 signal intensity increase due to cerebral edema may have been neutralized by 
the blood-oxygenation-level-dependent (BOLD) effect of hypoxia (Ogawa et al., 
1990a;Ogawa et al., 1990b). This effect is related to the intravascular concentration of 
deoxyhemoglobin, which lowers signal intensity of B0 images by increasing magnetic 
susceptibility (Lin et al., 1998;Prielmeier et al., 1994;Rostrup et al., 2005;van Zijl et al., 
1998). As hypoxia will increase the intravascular concentration of deoxyhemoglobin, it will 
also lower the intensity of the B0 signal and thus the level of perceived cerebral edema. 
Therefore, the BOLD effect might have prevented the detection of an association between the 
B0 values and the AMS-C scores. Consequently, it cannot be completely excluded that the 
mild extracellular cerebral edema is in part responsible for AMS, e.g. by stimulating pain 
sensitive fibers in the meninges, the meningeal and pial vessels (Sanchez and Moskowitz, 
1999). A potential role of vasogenic cerebral edema is underscored by two observations: 
Symptoms and signs of AMS as well as abnormal B0 values and ADCs occurring during 
exposure to isobaric hypoxia disappeared after the subjects were re-exposed to normoxia 
(Kallenberg et al., 2006), and corticosteroids, which reduce extracellular cerebral edema, are 
an established therapy of AMS (Ferrazzini et al., 1987).  
The third and most important result of the present study is based on the observation that 
subjects with the most severe AMS symptoms showed the lowest ADC values. Being in 
accordance with findings reported by Kallenberg et al. (2006), this would suggest that severe 
AMS is associated with intracellular (cytotoxic) edema of the cerebral white matter, on top of 
hypoxia-driven extracellular (vasogenic) edema. The cytotoxic edema may have been caused 
by a decreased activity and/or expression of the Na+, K+-ATPase in the cerebral white matter 
(Allen et al., 1992;De Angelis and Haupert, Jr., 1998;Nioka et al., 1990). A reduction of 
ATPase activity is associated with reduced levels of tissue ATP and a shift from aerobic to 
anaerobic glycolysis, and lactate is built up causing acidosis (Allen et al., 1992;Ben Yoseph et 
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al., 1993;Nioka et al., 1990). Using declining intracellular pH (pHi) as an indicator of 
increased intracellular lactate production, 31P MR spectroscopy (MRS) studies observed a pHi 
decline at arterial PO2 (PaO2) values of 30-45 mm Hg (Allen et al., 1992;Nioka et al., 
1990;Rolett et al., 2000). We observed PaO2 values of 40-45 mm Hg in subjects exposed to 
an altitude of 4559 m (Bartsch et al., 1990;Baumgartner et al., 2002). Consequently, the 
subjects investigated in this series were exposed to levels of hypoxia, which might lead to 
PaO2 values causing anaerobic glycolysis and reducing the cerebral metabolic rate of oxygen 
(CMRO2), although no study has shown a decrease of CMRO2 in humans exposed to high 
altitude (Moller et al., 2002;Severinghaus et al., 1966). However, the study of Severinghaus et 
al. (1966) was performed at a lower altitude of 3800 m, and the investigation of 
Moller(Moller et al., 2002) in subjects who were chronically exposed to high altitude. More 
important is that a recent study comparing MRI with positron emission tomography (PET) 
findings in patients with acute ischemic stroke has shown that ADCs are not reliable 
predictors of reduced CMRO2 at the levels of hypoxia applied in our subjects (Guadagno et 
al., 2006). These PET findings question the assumption that more severe forms of AMS are 
associated with intracellular (cytotoxic) edema. Further studies assessing also the CMRO2 in 
the cerebral white matter are needed to answer this question. 
The study is limited by the low number of included subjects. Furthermore, the present 
findings may not be applicable to hypobaric hypoxia, because the severity of AMS has been 
shown to be increased during simulated altitude compared with isobaric hypoxia (Roach et 
al., 1996). 
We conclude that experimental isobaric hypoxia is associated with mild extracellular 
(vasogenic) cerebral edema irrespective of the presence of AMS in the majority of subjects, 
and severe AMS with additional mild intracellular (cytotoxic) cerebral edema. 
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Figures legends 
 
Figure 1: Axial T2-weighted MR images show the 22 regions of interest. Slice A placed 
above slice B, and slices C and D placed at the level of the cella media of the lateral 
ventricles. 
 
Figure 2: Cerebral acute mountain sickness (AMS-C) scores of all subjects at baseline and 
during hypoxia. 
 
Figure 3: Axial diffusion-weighted (A) and T2-weighted (B) MR images obtained at baseline 
(upper rows) and after 6-hours exposure to hypoxia (lower rows) from subject 4 who suffered 
from severe acute mountain sickness. There is no evidence for the development of cerebral 
edema at visual inspection. 
 
Figure 4: Relative changes of the apparent diffusion coefficient (ADC) after 6 hours of 
hypoxia compared to baseline in all nine subjects. 
 
Figure 5: Relative changes of the B0 values after 6 hours of hypoxia compared to baseline in 
all nine subjects. 
 
Figure 6: The mean value of two cerebral acute mountain sickness (AMS-C) scores measured 
immediately before and after MR imaging performed at hypoxia showed a weak but 
significant negative correlation with the relative change of the apparent diffusion coefficient 
(ADC). 
 
Figure 7: The mean value of two cerebral acute mountain sickness (AMS-C) scores measured 
immediately before and after MR imaging performed at hypoxia showed no correlation with 
the relative change of the B0 signal intensity values. 
